ArticleClinical epigenetics2023

Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability.

Mohamed N Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.